(XT) iShares Exponential - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46434V3814

Tech Stocks, Robotics, Cloud, Biotech, CyberSecurity

Description: XT iShares Exponential

The iShares Exponential Technologies ETF (NASDAQ:XT) is an exchange-traded fund that tracks a subset of the Morningstar Global Markets Index, investing at least 80% of its assets in component securities or economically identical investments. This suggests a diversified portfolio with a focus on companies driving technological advancements.

To evaluate the funds performance, we can look beyond the provided technical and fundamental data. Key Performance Indicators (KPIs) such as the funds expense ratio, tracking error, and holdings diversification can offer insights into its operational efficiency and investment strategy. A lower expense ratio indicates lower costs for investors, while a lower tracking error suggests the fund more closely follows its underlying index.

Given the funds focus on exponential technologies, its likely to have a significant allocation to sectors such as technology, healthcare, and possibly industrials, where innovation is rapid. Investors should consider the funds sectoral weights, top holdings, and the overall growth prospects of its constituent companies. The funds AUM of $3.5 billion indicates a reasonable level of liquidity, but investors should also assess the liquidity of the underlying holdings.

To make an informed investment decision, one should analyze the funds historical performance, including its returns relative to the broader market and its benchmark index, as well as its risk-adjusted performance metrics such as the Sharpe ratio. Additionally, understanding the funds rebalancing strategy and tax efficiency can provide a more comprehensive view of its potential to meet investment objectives.

XT ETF Overview

Market Cap in USD 3,586m
Category Miscellaneous Sector
TER 0.46%
IPO / Inception 2015-03-19

XT ETF Ratings

Growth Rating 59.0%
Fundamental -
Dividend Rating 22.4%
Return 12m vs S&P 500 0.84%
Analyst Rating -

XT Dividends

Dividend Yield 12m 0.68%
Yield on Cost 5y 0.94%
Annual Growth 5y -2.29%
Payout Consistency 89.0%
Payout Ratio %

XT Growth Ratios

Growth Correlation 3m 85.2%
Growth Correlation 12m 61.1%
Growth Correlation 5y 25.6%
CAGR 5y 13.82%
CAGR/Max DD 3y 0.63
CAGR/Mean DD 3y 3.73
Sharpe Ratio 12m 1.00
Alpha 2.26
Beta 0.894
Volatility 14.82%
Current Volume 49.1k
Average Volume 20d 65k
Stop Loss 67.7 (-3.1%)
Signal 0.46

What is the price of XT shares?

As of September 16, 2025, the stock is trading at USD 69.89 with a total of 49,077 shares traded.
Over the past week, the price has changed by +0.27%, over one month by +4.80%, over three months by +9.72% and over the past year by +19.89%.

Is iShares Exponential a good stock to buy?

Partly, yes. Based on ValueRay´s Analyses, iShares Exponential (NASDAQ:XT) is currently (September 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.04 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XT is around 65.39 USD . This means that XT is currently overvalued and has a potential downside of -6.44%.

Is XT a buy, sell or hold?

iShares Exponential has no consensus analysts rating.

What are the forecasts/targets for the XT price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 73.4 5.1%

Last update: 2025-09-12 04:48

XT Fundamental Data Overview

Market Cap USD = 3.59b (3.59b USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 1.27
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.59b USD (3.59b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 3.59b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.59b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(3.59b)/V(0.0) * Re(9.31%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for XT ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle